FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Assurance Infusion TESTOSTERONE CYP 200MG/ML OIL INJ in 10 mL Recall

TESTOSTERONE CYP 200MG/ML OIL INJ in 10 mL vial Assurance Infusion (713) 533-8800

Assurance Infusion · Houston, TX

Risk level
Class II
Reported by FDA
Jan 22, 2020
Recall ID
D-0772-2020
Check your lot numberHow we source this data

Summary

Assurance Infusion recalled TESTOSTERONE CYP 200MG/ML OIL INJ in 10 mL starting Dec 20, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0772-2020 on Jan 22, 2020. Reason: Lack of sterility assurance. Status: Terminated.

Why it was recalled

Lack of sterility assurance.

Product description

TESTOSTERONE CYP 200MG/ML OIL INJ in 10 mL vial Assurance Infusion (713) 533-8800

Lot numbers, UPCs & expiration codes

Lots: 09122019@9 Exp. 03/10/2020; 09242019@9 Exp. 03/22/2020; 09192019@20 Exp. 03/17/2020; 10032019@8 Exp. 03/31/2020; 10032019@11 Exp. 03/31/2020; 10182019@5 Exp. 04/15/2020; 10242019@7 Exp. 04/21/2020; 10232019@24 Exp. 04/20/2020; 11042019@12 Exp. 05/02/2020; 11212019@3 Exp. 05/19/2020; 11212019@2 Exp. 05/19/2020; 11042019@15 Exp. 05/02/2020

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0772-2020
Classification
Class II
Status
Terminated
Recall initiated
Dec 20, 2019
FDA report date
Jan 22, 2020
Quantity
166 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Assurance Infusion

Original FDA data

Every field from FDA enforcement report D-0772-2020, exactly as published.

Show all FDA fields
City
Houston
State
TX
Status
Terminated
Country
United States
Event ID
84546
Address
2626 S Loop W Ste 555
Code information
Lots: 09122019@9 Exp. 03/10/2020; 09242019@9 Exp. 03/22/2020; 09192019@20 Exp. 03/17/2020; 10032019@8 Exp. 03/31/2020; 10032019@11 Exp. 03/31/2020; 10182019@5 Exp. 04/15/2020; 10242019@7 Exp. 04/21/2020; 10232019@24 Exp. 04/20/2020; 11042019@12 Exp. 05/02/2020; 11212019@3 Exp. 05/19/2020; 11212019@2 Exp. 05/19/2020; 11042019@15 Exp. 05/02/2020
Postal code
77054-2652
Report date
Jan 22, 2020
Product type
Drugs
Recall number
D-0772-2020
Classification
Class II
Recalling firm
Assurance Infusion
Product quantity
166 vials
Termination date
Oct 27, 2021
Reason for recall
Lack of sterility assurance.
Voluntary / mandated
Voluntary: Firm initiated
Product description
TESTOSTERONE CYP 200MG/ML OIL INJ in 10 mL vial Assurance Infusion (713) 533-8800
Distribution pattern
Nationwide within the United States
Recall initiation date
Dec 20, 2019
Initial firm notification
Letter
Center classification date
Jan 13, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0772-2020, published Jan 22, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls